|
| |
DynPort
| Contact Details: |
| 2121 Co-operative way |
| Herndon |
| VA |
| 20171 |
| United States of America |
| Tel: | 703 456 1023 |
| Fax: | 703 456 1099 |
| Email: | |
|
Loading...
|
Recent Publications by DynPort: |  |
Comparison of the immunological responses and efficacy of gamma-irradiated V3526 vaccine formulations against subcutaneous and aerosol challenge with Venezuelan equine encephalitis virus subtype IAB.
We recently developed a gamma-irradiation method to inactivate V3526, a... | 17th November, 2009
| DynPort Vaccine Company LLC (DVC), A CSC Company, 64 Thomas Johnson Drive,
| Vaccine. 2009 Nov 12.
DOI Direct Link |
A Multisystem Approach for Development and Evaluation of Inactivated Vaccines for Venezuelan Equine Encephalitis Virus (VEEV).
A multisystem approach was used to assess the efficiency of several... | 12th November, 2009
| DynPort Vaccine Company LLC (DVC), A CSC Company, 64 Thomas Johnson Drive,
| J Virol Methods. 2009 Nov 7.
DOI Direct Link |
Telemetric analysis to detect febrile responses in mice following vaccination with a live-attenuated virus vaccine.
Non-human primates (NHP) are considered to be the most appropriate model... | 19th September, 2009
| DynPort Vaccine Company LLC (DVC), A CSC Company, Frederick, MD 21702,
| Vaccine. 2009 Nov 16;27(49):6814-23. Epub 2009 Sep 15.
DOI Direct Link |
Immunotoxicology IV - innovative methods and applications for risk assessment in pharmaceutical development: introduction to the conference.
Assessment of neurovirulence is a standard test for vaccines derived from... | 3rd March, 2009
| DynPort Vaccine Company LLC, Frederick, Maryland 21702, USA.
| J Immunotoxicol. 2008 Jan;5(1):1.
DOI Direct Link |
Multidimensional immunomodulation.
Non-human primates (NHP) are considered to be the most appropriate model... | 30th October, 2008
| DynPort Vaccine Company LLC, Frederick, Maryland, USA.
| J Immunotoxicol. 2004 Apr;1(2):123-9.
DOI Direct Link |
→View more DynPort research publications. |
Press Releases on DynPort:
|
 |
| CSC's DVC Wins $32.3 Million NIAID Contract to Establish Phase 1 Clinical Trial Unit |
14th July, 2008 |
CSC |
FALLS CHURCH, Va., July 14 /PRNewswire-FirstCall/ -- CSC (NYSE: CSC)
announced today that DynPort Vaccine Company LLC (DVC), a CSC company, has
received a contract from the National Institute of
|
| CSC's DynPort Vaccine Company to Continue Plague Vaccine Development |
5th June, 2008 |
CSC |
FALLS CHURCH, Va., June 5 /PRNewswire/ -- CSC (NYSE: CSC) announced today
that DynPort Vaccine Company LLC (DVC), a CSC company, has been notified by
the Department of Defense (DoD) that all
|
 Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.
This page has been viewed 311 times since April 2007, the link to the organisation's website has been followed 0 times Recent Search Terms used to find this page: Dynport Vaccine Company | Dynport Vaccine Company | dynport vaccine company | dynport plague 2009 | Dynport | Dynport | DynPort history | DynPort history | . Search for more companies in Herndon Search for more companies in VA This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.BioPortfolio search results for DynPort |
